Abstract:Long QT syndrome is a disease of delayed ventricular repolarization. It manifests clinically as recurrent syncope and sudden cardiac death caused by an atypical form of polymorphic ventricular tachycardia known as torsades de pointes (TdP). Evidence obtained from the studies using the rabbit left and right ventricular wedge preparations indicates that the development of TdP is relying not only on the genesis of an R-on-T trigger, but also on the formation of a functional reentrant substrate. When ventricular endocardial or subendocardial repolarization is prolonged either because of gene mutations or by drugs that reduce the net repolarization current, cell membrane potential fluctuates during phase 2 of the action potential phase 2 because of reactivation of L-type calcium current, that is, the appearance of phase 2 early afterdepolarization (EAD). In the rabbit left ventricular wedge, QT prolongation and EAD due to pure IKr inhibition are accompanied by a disproportional increase in transmural dispersion of repolarization (TDR). Early afterdepolarization in endocardium or subendocardium is able to produce new action potentials in cells with a relatively short action potential duration (eg, ventricular epicardium) probably via an electrotonic effect when TDR is large enough. This, in turn, results in an R-on-T extrasystole that is capable of initiating TdP. Enhanced TDR is essential not only for the genesis of the first initiating beat of TdP by facilitating the propagation of EAD, but also for the maintenance of TdP by serving as a functional reentrant substrate.

Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes

Genetics of sudden death: focus on inherited channelopathies

Genetics of cardiac arrhythmias and sudden cardiac death

Evidence for a cardiac ion channel mutation underlying drug‐induced QT prolongation and life‐threatening arrhythmias

Ion Channel Disorders and Sudden Cardiac Death

Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders

Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management

Therapeutic strategies for long-QT syndrome: does the molecular substrate matter?

Drug‐induced torsades de pointes and implications for drug development

Torsade de pointes: mechanisms and management

Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation

Genetics of ion-channel disorders

Molecular biology of the long QT syndrome: impact on management

Identification of a long QT syndrome molecular defect in drug-induced torsades de pointes

Mechanisms underlying arrhythmogenesis in long QT syndrome

Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice

Exploring the hidden danger of noncardiac drugs.

Prevention of Torsade de Pointes in Hospital Settings

Inherited calcium channelopathies in the pathophysiology of arrhythmias

Inherited conditions of arrhythmia: translating disease mechanisms to patient management

Genetics, Molecular Mechanisms and Management of Long QT Syndrome